EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 238 filers reported holding EXELIXIS INC in Q1 2017. The put-call ratio across all filers is 0.89 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,342,041 | -69.9% | 244,487 | -73.6% | 0.02% | -67.6% |
Q2 2023 | $17,724,506 | -39.0% | 927,499 | -38.0% | 0.07% | -45.0% |
Q1 2023 | $29,038,990 | -12.1% | 1,496,084 | -27.4% | 0.13% | -19.4% |
Q4 2022 | $33,036,594 | +20.6% | 2,059,638 | +17.9% | 0.16% | +12.7% |
Q3 2022 | $27,393,000 | +3725.8% | 1,746,991 | +5410.3% | 0.14% | +4633.3% |
Q1 2021 | $716,000 | -70.8% | 31,704 | -74.1% | 0.00% | -70.0% |
Q4 2020 | $2,456,000 | -17.9% | 122,375 | +0.0% | 0.01% | -28.6% |
Q3 2020 | $2,992,000 | -78.1% | 122,360 | -78.8% | 0.01% | -78.8% |
Q2 2020 | $13,683,000 | +5797.8% | 576,386 | +4182.9% | 0.07% | +6500.0% |
Q1 2020 | $232,000 | -42.6% | 13,458 | -41.3% | 0.00% | -50.0% |
Q4 2019 | $404,000 | +37.9% | 22,928 | +67.1% | 0.00% | 0.0% |
Q2 2019 | $293,000 | -70.3% | 13,725 | -66.8% | 0.00% | -60.0% |
Q1 2019 | $985,000 | +83.4% | 41,369 | +51.5% | 0.01% | +66.7% |
Q4 2018 | $537,000 | -86.1% | 27,309 | -87.4% | 0.00% | -85.0% |
Q3 2018 | $3,855,000 | -30.0% | 217,559 | -14.9% | 0.02% | -33.3% |
Q2 2018 | $5,504,000 | -49.3% | 255,759 | -47.8% | 0.03% | -50.8% |
Q1 2018 | $10,849,000 | +48.7% | 489,819 | +104.1% | 0.06% | +52.5% |
Q4 2017 | $7,297,000 | +142.2% | 240,019 | +93.0% | 0.04% | +135.3% |
Q3 2017 | $3,013,000 | -81.5% | 124,352 | -81.1% | 0.02% | -83.3% |
Q2 2017 | $16,246,000 | +676.6% | 659,592 | +583.1% | 0.10% | +580.0% |
Q1 2017 | $2,092,000 | – | 96,552 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |